怀孕期间高血糖和后代的折射误差之间的关联:集中审查
Yufan Guo1,2,3,4, Jingru Lu1,2,3,4, Linlin Zhu1,2,3,4
1School of Public Health, Anhui Medical University, Hefei, Anhui Province, China.
European journal of ophthalmology
|March 25, 2024
概括
怀孕期间高血糖可能会损害您孩子的视力发育. 这可能导致折射误差,影响眼睛的结构和功能.
科学领域:
- 眼科医生 眼科 眼科
- 发展生物学 发展生物学
- 内分泌学 在内分泌学.
背景情况:
- 孕妇在怀孕期间患上高血糖症是一个越来越令人担忧的问题.
- 后代的视觉发育是复杂的,容易受到环境因素的影响.
- 折射误差是影响全球数百万人的常见视力障碍.
研究的目的:
- 审查关于母亲高血糖和后代折射误差之间的关联的现有文献.
- 评估子宫内高血糖症对后代视觉发育的影响.
- 综合关于将孕产妇高血糖与视力障碍联系起来的机制的发现.
主要方法:
- 在多个科学数据库中进行了全面的文献搜索.
- 纳入标准集中在研究怀孕期间高血糖和后代视觉发育的研究.
- 严格评估了所选研究的方法质量.
主要成果:
- 一致的证据表明,母亲高血糖会对后代的视觉发育产生负面影响.
- 子宫内高血糖环境对视网膜和透镜的发育产生不利影响.
- 研究结果表明,母亲高血糖和折射误差的发展之间存在联系.
结论:
- 怀孕期间的孕产妇高血糖症与后代发生折射误差的风险增加有关.
- 子宫内环境在视觉发育中起着至关重要的作用,高血糖症具有显著的风险.
- 需要进一步的研究来阐明具体的途径和潜在的干预措施.
相关概念视频
Pathophysiology of Diabetes
926
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
926
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
530
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
530
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Hypoglycemia and Glucagon
257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257


